Researchers at The University of Osaka and Kanazawa University have developed a novel method for analyzing cancer metabolism, revealing new insights into cancer's inefficient energy process. This breakthrough, published in Metabolic Engineering, combines biological experiments with advanced information science techniques to uncover the role of cancer-specific inefficient metabolism.

Bar-Ilan University and Sheba Medical Center are establishing a $120 million joint biotech research institute at Sheba’s new Health Tech Valley in Ramat Gan. Modeled after the U.S. NIH, the institute will bridge academia, healthcare, and industry to accelerate the translation of lab discoveries into clinical treatments. Research will focus on cancer, 3D organ printing, AI-driven medical data, robotics, genetic engineering, and microbiome science, with the aim of fast-tracking personalized medicine, new drugs, and advanced devices.

Leaders from both institutions stressed the institute’s role in positioning Israel as a global hub for biotech innovation, a magnet for billions in investment, and a powerful growth engine for the economy. 

Prof. Yitshak Kreiss, Director General of Sheba Medical Center: “The healthcare system is a powerful growth engine for the economy and industry."

Prof. Arie Zaban, President of Bar-Ilan University: "Biotechnology has become a focus of investment, drawing billions of shekels annually”.